Global Flu Vaccine Market Data Survey Report 2013-2025

Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.4 Scope of Type
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 AstraZeneca
  • 3.1.1 Company Information
  • 3.1.2 Product & Services
  • 3.1.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.1.4 Recent Development
• 3.2 CSL Limited
  • 3.2.1 Company Information
  • 3.2.2 Product & Services
  • 3.2.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.2.4 Recent Development
• 3.3 GSK
  • 3.3.1 Company Information
  • 3.3.2 Product & Services
  • 3.3.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.3.4 Recent Development
• 3.4 Hualun Biologicalsamong
  • 3.4.1 Company Information
  • 3.4.2 Product & Services
  • 3.4.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.4.4 Recent Development
• 3.5 ID Biomedical Corporation
  • 3.5.1 Company Information
  • 3.5.2 Product & Services
  • 3.5.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.5.4 Recent Development
• 3.6 Johnson & Johnson
  • 3.6.1 Company Information
  • 3.6.2 Product & Services
  • 3.6.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.6.4 Recent Development
• 3.7 MedImmune, LLC
  • 3.7.1 Company Information
  • 3.7.2 Product & Services
  • 3.7.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.7.4 Recent Development
• 3.8 Mylan
  • 3.8.1 Company Information
  • 3.8.2 Product & Services
  • 3.8.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.8.4 Recent Development
• 3.9 Novartis
  • 3.9.1 Company Information
  • 3.9.2 Product & Services
  • 3.9.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.9.4 Recent Development
• 3.10 Pfizer
  • 3.10.1 Company Information
  • 3.10.2 Product & Services
  • 3.10.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.10.4 Recent Development
• 3.11 Protein Sciences Corporaton
  • 3.11.1 Company Information
  • 3.11.2 Product & Services
  • 3.11.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.11.4 Recent Development
• 3.12 Sanofi Pasteur
  • 3.12.1 Company Information
  • 3.12.2 Product & Services
  • 3.12.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.12.4 Recent Development
• 3.13 Serum Institute of India
  • 3.13.1 Company Information
  • 3.13.2 Product & Services
  • 3.13.3 Business Data (Sales Revenue, Cost and Margin)
• 3.14 Sinovac Biotech
  • 3.14.1 Company Information
  • 3.14.2 Product & Services
  • 3.14.3 Business Data (Sales Revenue, Cost and Margin)

4 Major Application

• 4.1 Pediatrics
  • 4.1.1 Overview
  • 4.1.2 Pediatrics Market Size and Forecast
• 4.2 Adults
  • 4.2.1 Overview
  • 4.2.2 Adults Market Size and Forecast

5 Market by Ofvaccines

5.By Fluzone/Vaxigrip

• 5.1 Fluzone/Vaxigrip
  • 5.1.1 Overview
  • 5.1.2 Fluzone/Vaxigrip Market Size and Forecast
• 5.2 Anflu
  • 5.2.1 Overview
  • 5.2.2 Anflu Market Size and Forecast
• 5.3 FluMist
  • 5.3.1 Overview
  • 5.3.2 FluMist Market Size and Forecast
• 5.4 Fluarix
  • 5.4.1 Overview
  • 5.4.2 Fluarix Market Size and Forecast
• 5.5 FluLaval
  • 5.5.1 Overview
  • 5.5.2 FluLaval Market Size and Forecast
• 5.6 Fluvax/Afluria
  • 5.6.1 Overview
  • 5.6.2 Fluvax/Afluria Market Size and Forecast
• 5.7 Fluvirin
  • 5.7.1 Overview
  • 5.7.2 Fluvirin Market Size and Forecast
• 5.8 Others
  • 5.8.1 Overview
  • 5.8.2 Others Market Size and Forecast

6 Conclusion